Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pediatrics
Volume 2016, Article ID 8712962, 3 pages
http://dx.doi.org/10.1155/2016/8712962
Case Report

Regression of Cardiac Rhabdomyomas in a Neonate after Everolimus Treatment

1Department of Pediatric Cardiology, Kanuni Suleyman Teaching and Research Hospital, 34303 Istanbul, Turkey
2Department of Neonatology, Kanuni Suleyman Teaching and Research Hospital, 34303 Istanbul, Turkey
3Department of Pediatric Cardiology, Cerrahpasa Medical Faculty, Istanbul University, 34098 Istanbul, Turkey
4Department of Pediatric Hematology-Oncology, Kanuni Suleyman Teaching and Research Hospital, 34303 Istanbul, Turkey

Received 23 February 2016; Revised 17 May 2016; Accepted 30 May 2016

Academic Editor: Ozgur Cogulu

Copyright © 2016 Helen Bornaun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Karnak, D. Alehan, S. Ekinci, and N. Büyükpamukçu, “Cardiac rhabdomyoma as an unusual mediastinal mass in a newborn,” Pediatric Surgery International, vol. 23, no. 8, pp. 811–814, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Thomas-de-Montpréville, R. Nottin, E. Dulmet, and A. Serraf, “Heart tumors in children and adults: clinicopathological study of 59 patients from a surgical center,” Cardiovascular Pathology, vol. 16, no. 1, pp. 22–28, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Mariano, A. Pita, R. León et al., “Primary cardiac tumors in children: a 16-year experience,” Revista Portuguesa de Cardiologia, vol. 28, no. 3, pp. 279–288, 2009. View at Google Scholar · View at Scopus
  4. D. Tiberio, D. N. Franz, and J. R. Phillips, “Regression of a cardiac rhabdomyoma in a patient receiving everolimus,” Pediatrics, vol. 127, no. 5, pp. e1335–e1337, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. D. N. Franz, “Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis,” Expert Review of Anticancer Therapy, vol. 11, no. 8, pp. 1181–1192, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. H. A. Demir, F. Ekici, A. Y. Erdem, S. Emir, and B. Tunç, “Everolimus: a challenging drug in the treatment of multifocal inoperable cardiac rhabdomyoma,” Pediatrics, vol. 130, no. 1, pp. e243–e247, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Kutluk, H. A. Demir, M. Büyükpamukçu et al., “Cardiac rhabdomyomas in childhood: six cases from a single institution,” Turkish Journal of Pediatrics, vol. 55, no. 1, pp. 69–73, 2013. View at Google Scholar · View at Scopus
  8. R. S. Bader, D. Chitayat, E. Kelly et al., “Fetal rhabdomyoma: prenatal diagnosis, clinical outcome, and incidence of associated tuberous sclerosis complex,” The Journal of Pediatrics, vol. 143, no. 5, pp. 620–624, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Vinaitheerthan, J. Wei, M. Mizuguchi, M. A. Greco, and E. G. Barness, “Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus,” Fetal and Pediatric Pathology, vol. 23, no. 4, pp. 241–249, 2004. View at Publisher · View at Google Scholar · View at Scopus